GWEN VERLINGHIERI: Open Payments
NPI 1376784397 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 69 payments from 13 companies in 2025. Trend: 2023 $3,941 · 2024 $2,375 · 2025 $1,497
Food & beverage: $1,497
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 25 | $522 |
| Gilead Sciences, Inc. | 15 | $412 |
| Otsuka America Pharmaceutical, Inc. | 8 | $181 |
| Theratechnologies Inc. | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| ABBVIE INC. | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 3 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| Exact Sciences Corporation | 1 | $21 |
| Napo Pharmaceuticals Inc | 1 | $19 |
Products named: DOVATO, REXULTI, RUKOBIA, Biktarvy, EGRIFTA, CAPLYTA, VRAYLAR, HETLIOZ.
Industry payments across PA — which companies pay providers there.
